Posted On: 11/20/2015 11:26:22 PM
Post# of 72444
Check out this blast from the past.
http://www.gurufocus.com/news/153170/intervie...o-ehrlich-
"Thank you for taking the time to speak with us, Leo. First off, can you tell us why you decided to form Cellceutix?
Ehrlich: Thank you for having me. My mother had been diagnosed with stage four colon cancer and was receiving chemotherapy and experiencing difficulties due to the toxic treatments. I had already lost my father to cancer. I was discussing her condition with Dr. Krishna Menon, a dear friend of mine and a leading pharmaceutical researcher. I had great respect for Dr. Menon for his role in the development of Alimta and Gemzar, two of Eli Lilly and Company’s multi-billion dollar anti-cancer drugs. When we discussed his anti-cancer compounds in detail, I knew he was gifted in his capacity to understand cancer and its pharmacology. I then decided to invest my money with him at the helm, to find a better cancer treatment. It was an easy choice to form Cellceutix."
http://www.gurufocus.com/news/153170/intervie...o-ehrlich-
"Thank you for taking the time to speak with us, Leo. First off, can you tell us why you decided to form Cellceutix?
Ehrlich: Thank you for having me. My mother had been diagnosed with stage four colon cancer and was receiving chemotherapy and experiencing difficulties due to the toxic treatments. I had already lost my father to cancer. I was discussing her condition with Dr. Krishna Menon, a dear friend of mine and a leading pharmaceutical researcher. I had great respect for Dr. Menon for his role in the development of Alimta and Gemzar, two of Eli Lilly and Company’s multi-billion dollar anti-cancer drugs. When we discussed his anti-cancer compounds in detail, I knew he was gifted in his capacity to understand cancer and its pharmacology. I then decided to invest my money with him at the helm, to find a better cancer treatment. It was an easy choice to form Cellceutix."
(0)
(0)Scroll down for more posts ▼
